UCSF Radiation Oncology Update 2021

10 $

+ Include: 4 videos + 35 pdfs, size: 8.3 GB

+ Target Audience: radiologist, oncologist

Description

+ Include: 4 videos + 35 pdfs, size: 8.3 GB

+ Target Audience: radiologist, oncologist

+ Sample video: contact me for sample video

+ Information:

Activity Start Date: April 23, 2021

Activity End Date: April 24, 2021

Overview
This year’s course is focused on the role of advanced technologies in radiation oncology, especially the challenging issue of selecting patients who stand to benefit most. The course will feature discussions of IMRT, SBRT, MRI, and particle therapy. We will discuss proposed clinical, radiologic and biologic selection methods which are gaining importance as systemic therapies become increasingly tolerable, potent, and complex. This course offers numerous practical case-based review sessions allowing for self-assessment and interaction with expert panelists.

Educational Objectives

Upon completion of this program, attendees should be able to:
• Describe molecular, immunologic, and imaging-based stratification of brain tumors;
• Integrate hormone therapy and precise radiation therapy in treating prostate cancer;
• Cite 3 major recent findings related to immunotherapy and oncogene addiction in lung cancer;
• Name 3 predictors of breast cancer response;
• Name two ways to reduce morbidity in head and neck cancer patients;
• Identify MR predictors of prognosis and early response in gastrointestinal cancer.

 

+ Topics:

*Note: these are continuous video recordings during the conference, they include individual lectures mentioned in the Detail section below

0001_MRO21002_Complete_Syllabus.pdf
001_MRO21002_Syllabus_Intro.pdf
1. Definitive and Postoperative Radiation for Brain Metastases in the Era of Targeted Therapy and Immunotherapy.pdf
10.Multimodality Management of Bladder Cancer.pdf
11.GU Case-based Learning- Self-assessment Session.pdf
12.Lung SBRT- Risky Situations and the Role of Immunotherapy.pdf
13.Stage III Non-small Cell Lung Cancer- Radiation Therapy in the Context of Oncogene Addiction and Immunotherapy.pdf
14.Small Cell Lung Cancer- Evolving Applications of Radiation Therapy and Immunotherapy.pdf
15.Optimizing Management of Oncogene Driven Oligometastasis.pdf
16.Thoracic Case-based Learning- Self-assessment Session.pdf
17.Molecular Predictors of Outcome for Ductal Carcinoma in situ.pdf
18.Hypofractionated Radiation Therapy for Breast Cancer.pdf
19.PET- and MRI-based Predictors of Response to Neoadjuvant Chemotherapy.pdf
2. Imaging-based Precision Re-Irradiation for Brain Tumors.pdf
20.Skin Care Interventions that Make a Difference.pdf
21. Breast Case-based Learning- Self-assessment Session.pdf
22.Proton Therapy at the Christie NHS and Europe.pdf
23.The Proton Therapy Landscape in the U.S. and What Comes Next.pdf
25.Contouring and Treatment Planning Consensus.pdf
26.Targeted Therapy vs Immunotherapy for Head and Neck Cancers.pdf
27.Principles of Oral Cavity Surgery and Morbidity Reduction.pdf
28.Comprehensive Thyroid Cancer Management.pdf
29. HN Case-based Learning- Self-assessment.pdf
3. Stereotactic Approaches for Spine Reirradiation.pdf
30.SBRT for Pancreatic Cancer- Evidence and Practical Tips.pdf
31.Organ Preservation in Rectal Cancer.pdf
32.MRI Response Assessment in Rectal Cancer.pdf
33.Gastrointestinal Case-based Learning- Self-assessment Session .pdf
4. Meningioma- Molecular and Imaging-based Prognostication.pdf
5. CNS Case-based Learning- Self-Assessment Session.pdf
6.MRI, SBRT, Proton Therapy, and Hormone Therapy for Prostate Cancer- What’s Best and What’s Next.pdf
7.The Status of Postoperative Radiation- Hypofractionation Hormone Therapy.pdf
8.Genomic Profiling for Therapy Selection in Prostate Cancer.pdf
9.Updates on SBRT and HDR Brachytherapy for Localized Prostate Cancer.pdf
April 23 AM.mp4
April 23 PM.mp4
April 24 AM.mp4
April 24 PM.mp4
MRO21021_Radiation_Oncology_Agenda.pdf

Reviews

There are no reviews yet.

Be the first to review “UCSF Radiation Oncology Update 2021”

Your email address will not be published. Required fields are marked *